The European Life Sciences Web Portal
This is a free web portal for the life sciences in Europe and Israel... » read more
- Galenica Makes $1.53b Cash Tender Offer for Relypsa (2016-07-21)
> Galenica will commence a tender offer to acquire all issued and outstanding Relypsa common stock for a cash consideration of USD 32 per share > Implied fully-diluted equity value of the offer amounts to approximately USD 1.53 billion > Acquisition affirms commi...
- Novacyt Announces Half Year 2016 Revenues (2016-07-20)
Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces its unaudited revenues for the six months ending 30 June 2016. Financial highlights > Consolidated Group sales in H1 were €5.0m, representi...
- Oliver Schacht Joins Supervisory Board of Protagen (2016-07-20)
Protagen AG, a leading specialist in the development of novel diagnostic tests and companion diagnostics (CDx) in the autoimmune field, today announced that Dr. Oliver Schacht, CEO of Curetis N.V., Holzgerlingen, has joined the company's Supervisory Board. Addition...
- Neovacs and Stellar Biotechnologies Launch Joint Venture (2016-07-19)
Administrative Board and Management Team Appointed NEOVACS (Alternext Paris: ALNEV) and STELLAR BIOTECHNOLOGIES Inc. (Nasdaq: SBOT) today announced the start of their joint venture company, Neostell SAS, with the holding of its first general assembly. At the m...
- Sartorius Acquires ViroCyt for $16m (2016-07-15)
• Acquisition expands bioanalytical portfolio of Lab Products & Services division • Specialist for virus quantification significantly speeds up R&D and time to clinic invirology Sartorius, a leading international pharmaceutical and laboratory tools provider...
- Merck Appoints Dietmar Eidens Chief Human Resources Officer (2016-07-15)
Merck, a leading science and technology company, today announced that Kai Beckmann, member of the Executive Board, will hand over the leadership of Human Resources (HR) to Dietmar Eidens (58) as of October 1. To date, Beckmann has performed this function concurrent...
- MRC Technology Monetises Royalties on Cancer Drug Keytruda (2016-07-15)
MRC Technology, a UK-based medical research charity, has monetised a portion of its royalty interest in a leading cancer drug, pembrolizumab (marketed by Merck & Co., Inc. as Keytruda®) with a private equity fund managed by DRI Capital (DRI) for US $150M (£115.6M)....
- Bayer Increases Monsanto Offer from $122 to $125 per Share (2016-07-14)
Monsanto all-cash offer increased to USD 125 per share on July 1 after additional information received in private discussions / Bayer has comprehensively addressed Monsanto’s questions concerning financing of the transaction / In addition to certain commitments to ...
- Boehringer Ingelheim Partners with University of Dundee (2016-07-14)
• Collaboration aims to develop PROteolysis TArgeting Chimeric molecules (PROTACs) – a new therapeutic modality that is able to degrade proteins playing a central role in disease processes • PROTACs and their new mechanism of action are expected to open n...
- F-Star Extends Collaboration with CD Lab at BOKU in Vienna (2016-07-14)
Strong academic bridge supports F-star’s leading, innovative position in immuno-oncology and bispecific antibodies F-star, a biopharmaceutical company developing novel bispecific antibodies with a focus on immuno-oncology, today announced the extension of a mu...
Life-Sciences-Europe.com is your doorway to the European life sciences!
[LSE] provides free, up-to-date and structured access to
in Europe and Israel.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSE] is 100% Made in Germany!Start here with the latest News!
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to email@example.com and simply fill the subject line with the word »LSE newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]